Noile-Immune Biotech Inc. (TYO:4893)
Japan flag Japan · Delayed Price · Currency is JPY
77.00
-4.00 (-4.94%)
Nov 18, 2026, 11:21 AM JST

Noile-Immune Biotech Ratios and Metrics

Millions JPY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3,3425,7597,3619,175--
Market Cap Growth
-51.77%-21.77%-19.77%---
Enterprise Value
91,6412,6453,519--
Last Close Price
81.00133.00170.00212.00--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-1151.831051.6129.03--
PB Ratio
1.041.471.561.61--
P/TBV Ratio
1.041.471.561.61--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-328.23377.9011.14--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.98-1.00-0.99-0.98-1.05-0.99
Asset Turnover
-0.000.000.060.140.03
Inventory Turnover
13.0010.404.863.652.003.14
Quick Ratio
59.7553.3068.5865.3613.4952.41
Current Ratio
61.0953.8269.2066.4813.6852.81
Return on Equity (ROE)
-19.91%-18.32%-18.52%-22.63%-9.10%-23.44%
Return on Assets (ROA)
-13.10%-11.31%-12.63%-9.31%-1.49%-13.79%
Return on Capital Employed (ROCE)
-23.60%-20.20%-22.60%-13.60%-2.50%-18.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-22.38%-13.77%-13.10%-12.32%--
Buyback Yield / Dilution
-0.09%-0.01%-4.41%-5.87%-2.23%-7.89%